Margaret B. Fraser and Joseph T. Fraser v. Wyeth and Wyeth Pharmaceuticals: A Connecticut federal judge has upheld a jury verdict that totals nearly $5.8 million in the case of a Lakeville woman who claimed she developed breast cancer after taking the menopause drug Prempro.
Drug maker Wyeth Inc., owned by Pfizer Inc., had asked U.S. District Judge Janet Bond Arterton to reverse the jury’s 2012 verdict and rule there was not enough evidence to support the decision. The defendants also filed a separate motion for a new trial. Arterton denied both requests in a written ruling released earlier this month.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
